Indatuximab Biosimilar - Research Grade

Human

SDC1

5mg/ml

Human IgG4 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH2854

P18827

Blue ice

Syndecan-1 (SDC1/CD138) is a heparan-sulphate proteoglycan and a defining marker of plasma cells, central to myeloma and matrix-biology research. This recombinant anti-human SDC1 monoclonal is an unconjugated, non-therapeutic analog of indatuximab, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, internalisation and binding studies, ADC-development workflows, reproducible controls, and in vivo plasma-cell-malignancy models, providing the consistency required for sustained, heavy-usage research.

Detects human SDC1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

4 weeks